Voyager Therapeutics, Inc. (VYGR) News
Track canonical SquawkNews coverage tagged to VYGR, Voyager Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
VYGR: Tau-targeting therapies and novel delivery platforms advance toward key clinical and partnership milestones
Three major catalysts this year include tau-targeting therapies, capsid proof-of-concept, and NeuroShuttle platform progress. Key tau antibody and gene therapy programs are advancing toward clinical milestones, with part
EQUITY | Sep 08, 2026, 08:46 PM UTC
L
Voyager Therapeutics to present at upcoming investor conferences
Voyager Therapeutics said it will participate in upcoming investor conferences, with a webcast available for the Wel… conference.
EQUITY | Sep 01, 2026, 12:07 PM UTC
L
VYGR - Voyager to Present at Upcoming Investor Conferences
VYGR - Voyager to Present at Upcoming Investor Conferences
EQUITY | Sep 01, 2026, 12:01 PM UTC
L
VYGR Additional VY1706 (Alzheimer's anti-tau Gene therapy) preclinical data bode well for program/company; reiterate BUY, $12PT @ Canaccord
VYGR Additional VY1706 (Alzheimer's anti-tau Gene therapy) preclinical data bode well for program/company; reiterate BUY, $12PT @ Canaccord
EQUITY | Jul 14, 2026, 12:18 PM UTC
H
Jim Cramer: TE Connectivity Is ‘Terrific,’ Buy This Industrial Stock
On CNBC’s “ Mad Money Lightning Round,” Jim Cramer recommended buying GE Vernova Inc. (NYSE: GEV ), adding that the Charitable Trust has a very big position in the stock. Lending support to his choice, Bernstein analyst
RATES | Jul 01, 2026, 11:49 AM UTC